PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPs

Published date30 April 2021
Subject MatterPatents,Jurisdiction,Proposed Amendments,Pharmaceutical Patents,Canada,The Patent Act,Pharmaceutical Industry,Health Canada,Patented Medicines,Patented Medicine Prices Review Board (PMPRB),Certificates of Supplementary Protection (CSPs)
AuthorAbigail Smith
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT